Bright green corp
BGXX 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
公司發布財報數據季度不足，尚無法提供評分
BGXX 近期報酬表現
8.48%
Bright green corp
6.23%
同產業平均
1.02%
S&P500
與 BGXX 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
GENE | Genetic technologies limited | - | 2 分 | 1 分 | - | 1 分 | |
DNTH | Dianthus therapeutics inc | 3 分 | 5 分 | 2 分 | 1 分 | 1 分 | |
PSNL | Personalis inc | 2 分 | 1 分 | 2 分 | 1 分 | 1 分 | |
NVCT | Nuvectis pharma inc | - | 2 分 | 2 分 | 1 分 | 1 分 | |
SCPH | Scpharmaceuticals inc | 4 分 | 1 分 | 2 分 | 2 分 | 1 分 |
- GENE Genetic technologies limited價值 -趨勢 2 分波段 1 分籌碼 -股利 1 分查看更多
BGXX 公司資訊
Bright Green Corporation is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured in exact formulations for research and pharmaceutical applications and as an active ingredient to consumer-based solutions. The Company is engaged in cannabis propagation, cultivation, and manufacturing of cannabis products, including cannabis flower, pre-rolls, concentrates, vape pens, capsules, tinctures, edibles, topicals and any other cannabis-related products requested for authorized sales. The Company plans to sell extracted oils from medicinal plants grown in these high-tech facilities and processed onsite through a system that vertically integrates the genetically altered growth of the plants to conform to automated growing systems. It also plans to cultivate and manufacture cannabis for federally sanctioned research, as well as perform authorized research on cannabis, including cannabinol (CBN), cannabigerol (CBG), and cannabidiol (CBD).